@FierceBiotech: FDA's former IT boss nails down industry gig. Report from FierceBiotechIT.com | Follow @FierceBiotech
@JohnCFierce: MannKind soars after inhaled Afrezza delivers positive PhIII results. Report | Follow @JohnCFierce
@RyanMFierce: Fate Therapeutics, founded by stem cell experts, targets $69 million IPO. Article | Follow @RyanMFierce
> Ligand Pharmaceuticals ($LGND) struck a global licensing pact with CURx Pharmaceuticals for the development and commercialization of Ligand's Captisol-enabled Topiramate Injection for partial onset or primary generalized tonic-clonic seizures in hospitalized epilepsy patients. Under the terms of the agreement, Ligand is eligible for more than $21 million in potential net milestone payments and net royalties on future sales of 6.0% to 7.5%. Release
> Oxford BioMedica says it is one of 7 companies to win funding under the 2013 Supporting Regenerative Medicines and Cell Therapies competition. Release
Pharma News
@FiercePharma: With Pfizer, Novartis out, Amgen faces 1 possible rival for Onyx, per Bloomberg: AstraZeneca. Article | Follow @FiercePharma
@EricPFierce: India's Aurobindo buys, boosts capacity in sterile injectables, a hot market. Story from FiercePharmaManufacturing.com | Follow @EricPFierce
@CarlyHFierce: Here's the release on Boehringer earnings - BI says Pradaxa, Trajenta, Spiriva driving growth. Release | Follow @CarlyHFierce
> Tivicay marks beginning of end in growth of HIV branded market, EP says. Story
> China sales rep says Novartis ordered her to bribe doctors. Report
> New Novartis chair Reinhardt embarks on strategic review. Are divestments next? More
@FierceMedDev: Bard's fate hangs with jury in latest vaginal mesh lawsuit. Article | Follow @FierceMedDev
@DamianFierce: Quintiles is buying Novella with its eye on emerging biotechs. News from FierceCRO.com | Follow @DamianFierce
@MarkHFierce: For LumiQuick, is it another case of regulators trying to assert control over a surging Dx industry? Item | Follow @MarkHFierce
> How did Israel become a hotbed for medical devices? Feature
> FDA sticks 'deadly' tag on Nova's glucose test strips. Report
> Accellent grows revenue but losses widen. Story
> Myriad soars despite rise of rivals. Article
Drug Delivery News
@MichaelGFierce: Virus-killing nanoviricides win orphan status for dengue fever. Story | Follow @MichaelGFierce
> Receptor-targeted antifolate drugs yield fewer side effects. More
> Bind files $80M IPO to support PhII nanotech cancer drug delivery. News
> 'Smart' DNA-based nanomeds self-assemble to release cancer drug. Story
> MannKind's inhaled insulin delivery tech passes PhIII trial. Article
> NanoMedical Systems snags $2.3M to develop drug-releasing implant. Item
And Finally… A new mouse study shows that adding sugar to your diet could prove quite toxic. Story